secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001062822-24-000020
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon CEO Lonnel Coats to retire effective July 7, 2024; board begins CEO search
--------------------------------------------------------------------------------

- Lonnel Coats notified retirement as CEO (principal executive officer) and board member, effective July 7, 2024.
- Board of directors has initiated a search for a new CEO, considering both internal and external candidates.
- No successor named; Coats continues until effective date.
- Lexicon Pharmaceuticals (LXRX) trades on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/form8-kcoatsretirement.htm
  HTML page:      https://secwatch.observer/filing/0001062822-24-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer